共 50 条
- [31] Efficacy and Safety of Autologous Stem Cell Transplantation Combined with Chimeric Antigen Receptor T-Cell Therapy in the Treatment of Refractory/Relapsed B-Cell LymphomaBLOOD, 2023, 142Ma, Lixia论文数: 0 引用数: 0 h-index: 0机构: Beijing Gobroad Boren Hosp, Dept Lymphoma & Myeloma Res Ctr, Beijing, Peoples R China Beijing Gobroad Boren Hosp, Dept Lymphoma & Myeloma Res Ctr, Beijing, Peoples R ChinaKe, Xiaoyan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Third Hosp, Beijing, Peoples R China Beijing Gobroad Boren Hosp, Dept Lymphoma & Myeloma Res Ctr, Beijing, Peoples R ChinaHu, Kai论文数: 0 引用数: 0 h-index: 0机构: Beijing Gobroad Boren Hosp, Dept Lymphoma & Myeloma Res Ctr, Beijing, Peoples R China Beijing Gobroad Boren Hosp, Dept Lymphoma & Myeloma Res Ctr, Beijing, Peoples R China
- [32] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemiaHAEMATOLOGICA, 2024, 109 (04) : 1019 - 1020Rapoport, Aaron P.论文数: 0 引用数: 0 h-index: 0机构: Univ Maryland, Sch Med, Baltimore, MD 21201 USA Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA Univ Maryland, Sch Med, Baltimore, MD 21201 USA
- [33] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemiaREVISTA CHILENA DE LITERATURA, 2024, (109): : 1019 - 1020Rapoport, Aaron P.论文数: 0 引用数: 0 h-index: 0机构: Univ Maryland, Sch Med, Baltimore, MD 21250 USA Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21250 USA Univ Maryland, Sch Med, Baltimore, MD 21250 USA
- [34] CD19 and CD22-directed biespecific CAR for B-cell Acute Lymphoblastic LeukemiaHUMAN GENE THERAPY, 2019, 30 (11) : A54 - A54Zanetti, S. R.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukemia Res Inst, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainVelasco-Hernandez, T.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukemia Res Inst, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainGutierrez-Aguera, F.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukemia Res Inst, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainRoca-Ho, H.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukemia Res Inst, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainSanchez-Martinez, D.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukemia Res Inst, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainPetazzi, P.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukemia Res Inst, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainTorres, R.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukemia Res Inst, Barcelona, Spain Ctr Nacl Invest Oncol, Madrid, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainMolina, O.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukemia Res Inst, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainTorrebadell-Burriel, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp St Joan Deu, Hematol Lab, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainVidriales-Vicente, M. B.论文数: 0 引用数: 0 h-index: 0机构: Complejo Asistencial Univ Salamanca, Serv Hematol, Inst Invest Biomed Salamanca, Salamanca, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainHrusak, O.论文数: 0 引用数: 0 h-index: 0机构: Charles Univ Prague, Dept Pediat Hematol Oncol, Fac Med, Univ Hosp Motol, Prague, Czech Republic Josep Carreras Leukemia Res Inst, Barcelona, SpainFuster, J. L.论文数: 0 引用数: 0 h-index: 0机构: Hosp Virgen de Arrixaca, Secc Oncohematol Pediat, Murcia, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainJuan, M.论文数: 0 引用数: 0 h-index: 0机构: Hosp St Joan Deu, Dept Immunol, CDB, Hosp Clin Barcelona, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainBueno, C.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukemia Res Inst, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, SpainMenendez, P.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukemia Res Inst, Barcelona, Spain Univ Barcelona, Sch Med, Dept Biomed, Barcelona, Spain ISCIII, CIBER ONC, Barcelona, Spain ICREA, Barcelona, Spain Josep Carreras Leukemia Res Inst, Barcelona, Spain
- [35] A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemiaBONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1208 - 1217Hu, Yongxian论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaWang, Jiasheng论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaWei, Guoqing论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaYu, Jian论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaLuo, Yi论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaShi, Jimin论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaWu, Wenjun论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaZhao, Kui论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, PETCT Ctr, Bone Marrow Transplantat Ctr, Affiliated Hosp 1,Sch Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaXiao, Lei论文数: 0 引用数: 0 h-index: 0机构: Innovat Cellular Therapeut Co Ltd, Shanghai, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaZhang, Yanlei论文数: 0 引用数: 0 h-index: 0机构: Shanghai YaKe Biotechnol Ltd, Shanghai, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaWu, Zhao论文数: 0 引用数: 0 h-index: 0机构: Innovat Cellular Therapeut Co Ltd, Shanghai, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaXu, Huijun论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaChang, Alex Hongsheng论文数: 0 引用数: 0 h-index: 0机构: Shanghai YaKe Biotechnol Ltd, Shanghai, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R ChinaHuang, He论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China Zhejiang Prov Engn Lab Stem Cell & Immun Therapy, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China
- [36] Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell LymphomaCELLS, 2022, 11 (24)Huang, Lefu论文数: 0 引用数: 0 h-index: 0机构: Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R China Lu Daopei Inst Hematol, Beijing 100176, Peoples R China Hebei Yanda Lu Daopei Hosp, Langfang 065201, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R ChinaLi, Jingjing论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang 065201, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R ChinaYang, Junfang论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang 065201, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R ChinaZhang, Xian论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang 065201, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R ChinaZhang, Min论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang 065201, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R ChinaHe, Jiujiang论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang 065201, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R ChinaZhang, Gailing论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang 065201, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R ChinaLi, Wenqian论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang 065201, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R ChinaWang, Hui论文数: 0 引用数: 0 h-index: 0机构: Hebei Yanda Lu Daopei Hosp, Langfang 065201, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R ChinaLi, Jianqiang论文数: 0 引用数: 0 h-index: 0机构: Hebei Senlang Biotechnol Co Ltd, Shijiazhuang 050000, Peoples R China Hebei Med Univ, Dept Immunol, Key Lab Immune Mech & Intervent Serious Dis Hebei, Shijiazhuang 050000, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R ChinaLu, Peihua论文数: 0 引用数: 0 h-index: 0机构: Lu Daopei Inst Hematol, Beijing 100176, Peoples R China Hebei Yanda Lu Daopei Hosp, Langfang 065201, Peoples R China Tsinghua Univ, Dept Basic Med Sci, Sch Med, Beijing 100084, Peoples R China
- [37] A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemiaBone Marrow Transplantation, 2019, 54 : 1208 - 1217Yongxian Hu论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineJiasheng Wang论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineGuoqing Wei论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineJian Yu论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineYi Luo论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineJimin Shi论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineWenjun Wu论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineKui Zhao论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineLei Xiao论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineYanlei Zhang论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineZhao Wu论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineHuijun Xu论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineAlex Hongsheng Chang论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of MedicineHe Huang论文数: 0 引用数: 0 h-index: 0机构: Zhejiang University,Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine
- [38] CD19 Chimeric Antigen Receptor Therapy for Refractory Aggressive B-Cell LymphomaJOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04) : 328 - +Jacobson, Caron A.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA
- [39] Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell MalignanciesJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (03): : 436 - 445Garcia-Prieto, Carlos A.论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain Barcelona Supercomp Ctr BSC, Life Sci Dept, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainVillanueva, Lorea论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainBueno-Costa, Alberto论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainDavalos, Veronica论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainAzucena Gonzalez-Navarro, Europa论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Dept Immunol, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainJuan, Manel论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Dept Immunol, Barcelona, Spain Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainUrbano-Ispizua, Alvaro论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain Univ Barcelona UB, Dept Hematol, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainDelgado, Julio论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainOrtiz-Maldonado, Valentin论文数: 0 引用数: 0 h-index: 0机构: Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainDel Bufalo, Francesca论文数: 0 引用数: 0 h-index: 0机构: IRCCS, Dept Paediat Haematol & Oncol, Bambino Gesu Childrens Hosp, Cell & Gene Therapy, Rome, Italy Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainLocatelli, Franco论文数: 0 引用数: 0 h-index: 0机构: IRCCS, Dept Paediat Haematol & Oncol, Bambino Gesu Childrens Hosp, Cell & Gene Therapy, Rome, Italy Sapienza Univ Rome, Dept Pediat, Rome, Italy Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain论文数: 引用数: h-index:机构:Sinibaldi, Matilde论文数: 0 引用数: 0 h-index: 0机构: IRCCS, Dept Paediat Haematol & Oncol, Bambino Gesu Childrens Hosp, Cell & Gene Therapy, Rome, Italy Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainSoler, Marta论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainCastro de Moura, Manuel论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainFerrer, Gerardo论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainUrdinguio, Rocio G.论文数: 0 引用数: 0 h-index: 0机构: Univ Oviedo, Nanomat & Nanotechnol Res Ctr CINNCSIC, Inst Oncol Asturias IUOPA,Ctr Invest Biomed Red E, Hlth Res Inst Asturias ISPA,Dept Organisms & Syst, Oviedo, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainFernandez, Agustin F.论文数: 0 引用数: 0 h-index: 0机构: Univ Oviedo, Nanomat & Nanotechnol Res Ctr CINNCSIC, Inst Oncol Asturias IUOPA,Ctr Invest Biomed Red E, Hlth Res Inst Asturias ISPA,Dept Organisms & Syst, Oviedo, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainFraga, Mario F.论文数: 0 引用数: 0 h-index: 0机构: Univ Oviedo, Nanomat & Nanotechnol Res Ctr CINNCSIC, Inst Oncol Asturias IUOPA,Ctr Invest Biomed Red E, Hlth Res Inst Asturias ISPA,Dept Organisms & Syst, Oviedo, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainBar, Diana论文数: 0 引用数: 0 h-index: 0机构: Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Div Pediat Hematol & Oncol, Ramat Gan, Israel Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainMeir, Amilia论文数: 0 引用数: 0 h-index: 0机构: Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Div Pediat Hematol & Oncol, Ramat Gan, Israel Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainItzhaki, Orit论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Ella Lemelbaum Inst Immuno Oncol, Ramat Gan, Israel Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainBesser, Michal J.论文数: 0 引用数: 0 h-index: 0机构: Sheba Med Ctr, Ella Lemelbaum Inst Immuno Oncol, Ramat Gan, Israel Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainAvigdor, Abraham论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel Sheba Med Ctr, Inst Hematol, Ramat Gan, Israel Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainJacoby, Elad论文数: 0 引用数: 0 h-index: 0机构: Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Div Pediat Hematol & Oncol, Ramat Gan, Israel Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, SpainEsteller, Manel论文数: 0 引用数: 0 h-index: 0机构: Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain Univ Barcelona UB, Sch Med & Hlth Sci, Physiol Sci Dept, Barcelona, Spain Josep Carreras Leukaemia Res Inst IJC, Canc & Leukemia Epigenet & Biol Program PEBCL, Barcelona, Spain
- [40] CD19 regulates CD22 function in B cell development and B cell antigen receptor signal transductionFASEB JOURNAL, 1999, 13 (05): : A987 - A987Bradney, AP论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USAFujimoto, M论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USAPoe, JC论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USATedder, TF论文数: 0 引用数: 0 h-index: 0机构: Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA